successful product will prevail, page-8

Do the calculations!

J.P. Morgan is out with its report today on Dendreon (NASDAQ: DNDN), reiterating Overweight after visiting DNDN's newly constructed Provenge facility.

In a note to clients, J.P. Morgan writes, "This was a productive trip that reinforced our high level of conviction in DNDN. Whether investors wait for greater execution comfort in March (NJ facility approval and CMS memo) or a demand sneak peak with 2Q sales results this summer (the first at heightened capacity), we do expect the main bear stories to be addressed in the NT that could allow for significant appreciation of DNDN shares."

J.P. Morgan has a $66 PT on DNDN.

Shares of DNDN closed Friday at $35.51, up 2.42% from Thursday's close

Read more: http://www.benzinga.com/analyst-ratings/analyst-color/11/02/838654/j-p-morgan-reiterates-overweight-on-dendreon-dndn#ixzz1DHvE8DI3